Oral semaglutides multifaceted therapeutic potential goes beyond glycemic control to address associated conditions such as obesity, CVD, and CKD, making it a valuable option for a wide range of patients
La condotta corretta non sospendere il GLP-1, ma valutare una riduzione della dose di insulina o della sulfonilurea, con monitoraggio glicemico appropriato
The standard approach goes something like this: You fill out a questionnaire A provider you never meet approves your prescription Medication arrives in your mailbox You're left alone to figure out the rest The Typical Telehealth Experience Meet Vanessa, one of our patients who previously tried semaglutide through another telehealth provider
This FDA approval offers an additional tool to address this serious, chronic, progressive disease. In addition to the usual safety information for this class of medications, the product label suggests discontinuing Wegovy before attempting pregnancy (for both females and males), and stopping if an unplanned pregnancy occurs